[HTML][HTML] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
Background To investigate the safety and activity of cetuximab in the pre-operative treatment
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …
[引用][C] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
S SCHMITZ, M HAMOIR, M LONNEUX… - Annals of …, 2013 - pascal-francis.inist.fr
Tumour response and safety of cetuximab in a window pre-operative study in patients with
squamous cell carcinoma of the head and neck CNRS Inist Pascal-Francis CNRS Pascal …
squamous cell carcinoma of the head and neck CNRS Inist Pascal-Francis CNRS Pascal …
[PDF][PDF] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
S Schmitz, M Hamoir, H Reychler, M Magremanne… - 2013 - researchgate.net
Background: To investigate the safety and activity of cetuximab in the pre-operative
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …
[引用][C] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.
S Schmitz, M Hamoir, H Reychler… - Annals of …, 2013 - dial.uclouvain.be
Short-course pre-operative administration of cetuximab is safe and shows a high rate of (18)
FDG-PET response.(18) FDG-PET response was correlated with residual tumour cellularity …
FDG-PET response.(18) FDG-PET response was correlated with residual tumour cellularity …
[PDF][PDF] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
S Schmitz, M Hamoir, H Reychler, M Magremanne… - 2013 - academia.edu
Background: To investigate the safety and activity of cetuximab in the pre-operative
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …
Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
S Schmitz, M Hamoir, H Reychler… - Annals of …, 2013 - annalsofoncology.org
Background To investigate the safety and activity of cetuximab in the pre-operative treatment
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …
Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.
S Schmitz, M Hamoir, H Reychler… - Annals of Oncology …, 2013 - europepmc.org
Tumour response and safety of cetuximab in a window pre-operative study in patients with
squamous cell carcinoma of the head and neck. - Abstract - Europe PMC Sign in | Create an …
squamous cell carcinoma of the head and neck. - Abstract - Europe PMC Sign in | Create an …
Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
S Schmitz, M Hamoir, H Reychler… - Annals of oncology …, 2013 - pubmed.ncbi.nlm.nih.gov
Background To investigate the safety and activity of cetuximab in the pre-operative treatment
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …
of squamous cell carcinoma of the head and neck (SCCHN). Patients and methods …
[PDF][PDF] Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
S Schmitz, M Hamoir, H Reychler, M Magremanne… - 2013 - academia.edu
Background: To investigate the safety and activity of cetuximab in the pre-operative
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …
treatment of squamous cell carcinoma of the head and neck (SCCHN). Patients and …